Cancer Letters
Volume 210, Issue 1 , Pages 101-109, 8 July 2004

p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy

  • Reiping Tang

      Affiliations

    • Department of Colorectal Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC
  • ,
  • Jeng-Yi Wang

      Affiliations

    • Department of Colorectal Surgery, Chang Gung Memorial Hospital, Jar-Yi, Taiwan, ROC
  • ,
  • Chung-Wei Fan

      Affiliations

    • Department of Colorectal Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC
  • ,
  • Kuo-Chien Tsao

      Affiliations

    • Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC
  • ,
  • Hong-Hua Chen

      Affiliations

    • Department of Colorectal Surgery, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, ROC
  • ,
  • Chi-Ming Wu

      Affiliations

    • Graduate Institute of Basic Medical Science, Chang Gung University, Tao-Yuan, Taiwan, ROC
  • ,
  • Jinn-Shiun Chen

      Affiliations

    • Department of Colorectal Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC
  • ,
  • Chung Rong Changchien

      Affiliations

    • Department of Colorectal Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC
  • ,
  • Ling-Ling Hsieh

      Affiliations

    • Department of Public Health, Chang Gung University, 259 Wen-Hwa 1 Road, Kwei-San, Tao-Yuan 333, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +886-3-211-8800x5125; fax: +886-3-211-8700

Received 8 August 2003; received in revised form 10 January 2004; accepted 15 January 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(04)00050-3

doi:10.1016/j.canlet.2004.01.006

Cancer Letters
Volume 210, Issue 1 , Pages 101-109, 8 July 2004